United Kingdom: AI Supporting Early Diagnosis of Lung Cancer
The British National Health Service (NHS) has announced its intention to launch innovative clinical trials that combine artificial intelligence and robotic assistance to accelerate the diagnosis of lung cancer, the deadliest form of cancer in the UK.
A Cutting-Edge Technology for Faster Screening
The project, which will take place at the Guy and St Thomas’ Hospital in London, aims to detect the disease at an early stage, allowing for immediate treatment and significantly increasing the chances of patient survival.
The system will rely on an artificial intelligence program capable of analyzing lung images and identifying nodules measuring up to six millimeters. Following this, a robotic camera will guide precision instruments to collect and analyze tissue samples with superior accuracy compared to traditional methods.
Screening for “Hidden” Nodules
This technology will also enable access to nodules deeply embedded in the lungs, often previously inaccessible or difficult to detect, thereby improving early detection rates.
The NHS plans to extend this screening to all smokers and former smokers by 2030, with the goal of diagnosing approximately 50,000 cases by 2035, including 23,000 at an early stage, which could potentially save thousands of lives each year.
A Major Public Health Challenge
Lung cancer remains a public health challenge in the UK, causing approximately 33,100 annual deaths, or 91 deaths per day, making it a national priority in the fight against cancer.
